TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
TLSA

Tiziana Life Sciences Ltd

Healthcare · Biotechnology

1.10$ +2.7% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Tiziana Life Sciences Ltd (TLSA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 11 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TLSA
Line item Q1 16 Q2 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
– 8.4 5.1 – 2.4 1.8 1.8 1.8 1.7 77 5.5 6.9 2.1 – 1.8 2.4 13 – 71 71 58 – 49 49 35 – 26 26 17 17 12 12 11 11 11 11 17 17 11 11
– 8.4 5.0 – 2.3 1.8 1.8 1.8 1.7 77 5.4 6.9 1.5 1.5 1.1 1.5 12 70 70 70 57 49 49 49 32 24 24 24 15 15 7.3 7.3 7.8 7.8 7.5 7.5 13 13 8.6 8.6
– 8.3 4.7 – 2.0 0.0 0.0 0.1 0.1 59 4.2 5.3 0.4 – 0.2 0.2 9.0 – 66 66 53 – 42 42 26 – 18 18 6.6 6.6 1.2 1.2 1.1 1.1 3.7 3.7 7.3 7.3 4.0 4.0
– 8.3 4.7 – 2.0 – 0.0 0.0 0.1 0.0 4.2 5.3 0.4 – 0.2 0.2 9.0 – 66 66 53 – 42 42 26 – 18 18 6.6 6.6 1.2 1.2 1.1 1.1 3.7 3.7 7.3 7.3 – 4.0
– – 0.1 – 0.1 1.5 1.5 1.4 1.3 14 0.2 1.3 1.4 1.3 1.3 2.1 2.6 3.6 3.8 3.8 2.8 5.3 5.3 5.3 4.9 5.9 6.0 6.0 8.6 7.9 6.1 6.1 6.6 6.3 3.7 3.7 4.9 4.9 – 4.3
– – – – 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – 0.6 0.6 – – – – – – – – – – – – – – – – – – – –
– – 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 – – – – – – – – – – – – –
– – – – 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – 0.0 – – – – – – – – – – – – – – – – – – – –
– – – – 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – 0.1 0.1 0.1 – 0.1 0.1 0.1 – – – – – – – – – – – – – – –
– 0.9 1.7 – 2.3 3.5 3.5 6.4 6.0 72 5.0 6.4 5.1 – 6.0 7.9 6.9 – 8.3 8.3 9.2 – 7.5 7.5 5.3 – 6.9 6.9 4.1 4.1 6.6 6.6 9.1 9.1 7.3 7.3 7.4 7.4 11 11
– 0.9 1.7 – 2.3 3.5 3.5 5.8 5.4 72 5.0 6.4 6.1 7.4 5.6 7.3 6.5 8.0 8.0 8.0 8.8 7.5 7.5 7.5 5.3 6.7 6.7 6.7 3.9 3.9 6.5 6.5 9.1 9.1 7.3 7.3 7.4 7.4 11 11
– 0.2 0.2 – 0.0 – 0.2 0.0 0.3 0.0 0.2 0.3 0.5 – 0.2 0.3 0.7 – 0.2 2.3 1.0 – – – – – 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.1 0.2 0.1 0.1 – 0.2
– 0.6 1.2 – 2.3 2.8 2.8 4.8 4.5 41 2.9 3.8 4.2 4.2 3.2 4.2 3.2 3.4 3.4 3.4 3.8 4.4 4.4 4.4 4.4 6.5 5.0 5.0 2.9 2.9 4.1 4.1 7.5 7.5 5.6 5.6 – 5.2 7.2 7.2
– – – – 0.0 – 0.0 0.6 0.4 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – –
– 7.5 3.3 – 0.1 -1.7 -1.7 -4.5 -4.2 5.9 0.4 0.5 -3.0 – -4.2 -5.5 6.2 – 46 46 49 – 41 41 30 – 20 20 13 13 5.5 5.5 1.9 1.9 3.9 3.9 9.2 9.2 0.1 0.1
– -15 11 – 6.8 -30 -30 -47 -44 -36 -40 -51 -39 -60 -43 -57 -59 -85 -85 -85 -103 -108 -108 -108 -112 -116 2.4 2.4 -125 -125 -134 -134 -138 -138 -145 -145 -32 -32 -163 -44
47 47 53 53 53 87 64 64 64 1,358 68 68 68 – 68 137 75 – 195 44 75 – 102 111 51 – 50 50 51 51 51 51 52 52 111 55 58 58 121 59

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?